Dobutrex Pregnancy Warnings
Animal studies have failed to reveal evidence of fetotoxicity. There are no controlled data in human pregnancy.
AU TGA pregnancy category B2: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.
US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus and there are no alternatives.
AU TGA pregnancy category: B2
US FDA pregnancy category: B
See references
Dobutrex Breastfeeding Warnings
Breastfeeding is not recommended during use of this drug.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
According to some authorities, if this drug does appear in breast milk, it is unlikely to affect the infant due to poor bioavailability and short half-life.
See references
